HSIL, High-Grade Squamous Intraepithelial Lesions: Clinical Trials

2 trials for HSIL, High-Grade Squamous Intraepithelial Lesions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1

Follow HSIL, High-Grade Squamous Intraepithelial Lesions: new trials by email Literature Review of HSIL, High-Grade Squamous Intraepithelial Lesions trials Research Report on HSIL, High-Grade Squamous Intraepithelial Lesions

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
Topical ABI-1968 cream - HSIL, High-Grade Squamous Intraepithelial Lesions, Human Papilloma Virus Infection
Phase 1TerminatedAntiva Biosciences62018-12-172019-07-24
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
ABI-1968 - HSIL, High-Grade Squamous Intraepithelial Lesions, Human Papilloma Virus Infection
Phase 1CompletedAntiva Biosciences572017-08-112019-02-07

Narrower conditions

Anus Neoplasms (2)  ·  HIV Infections (2)  ·  Papillomavirus Infections (2)  ·  Squamous Intraepithelial Lesions (2)

Broader conditions

Anus Diseases (2)  ·  Blood-Borne Infections (2)  ·  Colorectal Neoplasms (2)  ·  Communicable Diseases (2)  ·  DNA Virus Infections (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Disease Attributes (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Genital Diseases (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Infections (2)  ·  Intestinal Diseases (2)

Sponsors

Antiva Biosciences (2)

Countries

Australia (2)  ·  United States (2)